• Je něco špatně v tomto záznamu ?

Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin

S. Legartová, A. Jugová, L. Stixová, S. Kozubek, M. Fojtová, Z. Zdráhal, G. Lochmanová, E. Bártová,

. 2013 ; 95 (2) : 167-79.

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031856

Apoptotic bodies are the most condensed form of chromatin. In general, chromatin structure and function are mostly dictated by histone post-translational modifications. Thus, we have analyzed the histone signature in apoptotic cells, characterized by pronounced chromatin condensation. Here, H2B mono-acetylation, and H3K9 and H4 acetylation was significantly decreased in apoptotic cells, which maintained a high level of H3K9 methylation. This phenotype was independent of p53 function and distinct levels of anti-apoptotic Bcl2 protein. Interestingly, after etoposide treatment of leukemia and multiple myeloma cells, H3K9 and H4 hypoacetylation was accompanied by increased H3K9me2, but not H3K9me1 or H3K9me3. In adherent mouse fibroblasts, a high level of H3K9me3 and histone deacetylation in apoptotic bodies was likely responsible for the pronounced (∼40%) recovery of GFP-HP1α and GFP-HP1β after photobleaching. HP1 mobility in apoptotic cells appeared to be unique because limited exchange after photobleaching was observed for other epigenetically important proteins, including GFP-JMJD2b histone demethylase (∼10% fluorescence recovery) or Polycomb group-related GFP-BMI1 protein (∼20% fluorescence recovery). These findings imply a novel fact that only certain subset of proteins in apoptotic bodies is dynamic.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031856
003      
CZ-PrNML
005      
20131003100447.0
007      
ta
008      
131002s2013 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biochi.2012.09.027 $2 doi
035    __
$a (PubMed)23023195
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Legartová, Soňa $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Královopolská 135, 612 65 Brno, Czech Republic.
245    10
$a Epigenetic aspects of HP1 exchange kinetics in apoptotic chromatin / $c S. Legartová, A. Jugová, L. Stixová, S. Kozubek, M. Fojtová, Z. Zdráhal, G. Lochmanová, E. Bártová,
520    9_
$a Apoptotic bodies are the most condensed form of chromatin. In general, chromatin structure and function are mostly dictated by histone post-translational modifications. Thus, we have analyzed the histone signature in apoptotic cells, characterized by pronounced chromatin condensation. Here, H2B mono-acetylation, and H3K9 and H4 acetylation was significantly decreased in apoptotic cells, which maintained a high level of H3K9 methylation. This phenotype was independent of p53 function and distinct levels of anti-apoptotic Bcl2 protein. Interestingly, after etoposide treatment of leukemia and multiple myeloma cells, H3K9 and H4 hypoacetylation was accompanied by increased H3K9me2, but not H3K9me1 or H3K9me3. In adherent mouse fibroblasts, a high level of H3K9me3 and histone deacetylation in apoptotic bodies was likely responsible for the pronounced (∼40%) recovery of GFP-HP1α and GFP-HP1β after photobleaching. HP1 mobility in apoptotic cells appeared to be unique because limited exchange after photobleaching was observed for other epigenetically important proteins, including GFP-JMJD2b histone demethylase (∼10% fluorescence recovery) or Polycomb group-related GFP-BMI1 protein (∼20% fluorescence recovery). These findings imply a novel fact that only certain subset of proteins in apoptotic bodies is dynamic.
650    _2
$a acetylace $7 D000107
650    _2
$a zvířata $7 D000818
650    _2
$a fytogenní protinádorové látky $7 D000972
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a buněčná adheze $7 D002448
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a chromatin $x účinky léků $x genetika $x metabolismus $7 D002843
650    _2
$a chromozomální proteiny, nehistonové $x genetika $x metabolismus $7 D002868
650    _2
$a epigeneze genetická $x účinky léků $7 D044127
650    _2
$a etoposid $7 D005047
650    _2
$a fibroblasty $x cytologie $x účinky léků $x metabolismus $7 D005347
650    _2
$a histony $x genetika $x metabolismus $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a metylace $7 D008745
650    _2
$a myši $7 D051379
650    _2
$a posttranslační úpravy proteinů $x účinky léků $7 D011499
650    _2
$a protoonkogenní proteiny c-bcl-2 $x genetika $x metabolismus $7 D019253
650    _2
$a rekombinantní fúzní proteiny $x genetika $x metabolismus $7 D011993
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jugová, Alžběta $u -
700    1_
$a Stixová, Lenka $u -
700    1_
$a Kozubek, Stanislav $u -
700    1_
$a Fojtová, Miloslava $u -
700    1_
$a Zdráhal, Zbyněk $u -
700    1_
$a Lochmanová, Gabriela $u -
700    1_
$a Bártová, Eva $u -
773    0_
$w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 95, č. 2 (2013), s. 167-79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23023195 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20131003101005 $b ABA008
999    __
$a ok $b bmc $g 995943 $s 830301
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 95 $c 2 $d 167-79 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace